Top

Published in:

Open Access 01-12-2012 | Correspondence

Setting an agenda for comparative effectiveness systematic reviews in CKD care

Authors: Deidra C Crews, Raquel C Greer, Jeffrey J Fadrowski, Michael J Choi, David Doggett, Jodi B Segal, Kemi A Fawole, Pammie R Crawford, L Ebony Boulware

Published in: BMC Nephrology | Issue 1/2012

Abstract

Systematic reviews comparing the effectiveness of strategies to prevent, detect, and treat chronic kidney disease are needed to inform patient care. We engaged stakeholders in the chronic kidney disease community to prioritize topics for future comparative effectiveness research systematic reviews. We developed a preliminary list of suggested topics and stakeholders refined and ranked topics based on their importance. Among 46 topics identified, stakeholders nominated 18 as ‘high’ priority. Most pertained to strategies to slow disease progression, including: (a) treat proteinuria, (b) improve access to care, (c) treat hypertension, (d) use health information technology, and (e) implement dietary strategies. Most (15 of 18) topics had been previously studied with two or more randomized controlled trials, indicating feasibility of rigorous systematic reviews. Chronic kidney disease topics rated by stakeholders as ‘high priority’ are varied in scope and may lead to quality systematic reviews impacting practice and policy.

Available only for authorised users

Mehrotra R: Bridging the care gap around dialysis initiation: Is CKD education part of the solution?. Am J Kidney Dis. 2011, 58 (2): 160-161. 10.1053/j.ajkd.2011.06.002.CrossRefPubMed

Smith DH, Thorp ML: Nurse-coordinated care in CKD: time for translation into practice?. Clin J Am Soc Nephrol. 2011, 6 (6): 1229-1231. 10.2215/CJN.03620411.CrossRefPubMed

Pauly RP, Tonelli M: Predicting development of CKD in the general population–early days in a rapidly evolving field. Am J Kidney Dis. 2011, 57 (6): 805-807. 10.1053/j.ajkd.2011.02.378.CrossRefPubMed

Litvin CB, Nietert PJ, Wessell AM, Jenkins RG, Ornstein SM: Recognition and management of CKD in primary care. Am J Kidney Dis. 2011, 57 (4): 646-647. 10.1053/j.ajkd.2010.11.013.CrossRefPubMedPubMedCentral

Ikizler TA: CKD classification: time to move beyond KDOQI. J Am Soc Nephrol. 2009, 20 (5): 929-930. 10.1681/ASN.2009030309.CrossRefPubMed

Fink JC, Chertow GM: Medication errors in chronic kidney disease: one piece in the patient safety puzzle. Kidney Int. 2009, 76 (11): 1123-1125. 10.1038/ki.2009.315.CrossRefPubMed

Wasse H, McClellan WM: Increasing physician knowledge about the diagnosis and management of CKD: how can we help primary care providers?. Am J Kidney Dis. 2009, 54 (2): 187-190. 10.1053/j.ajkd.2009.05.002.CrossRefPubMed

Federal Coordinating Council for Comparative Effectiveness Research: Report to the President and the Congress. June 2009, Department of Health and Human Services, Washington, DC, Accessed January 10, 2012, at http://www.hhs.gov/recovery/programs/cer/cerannualrpt.pdf

Agency for Healthcare Research and Quality: Recovery Act Awards. September 2010, Rockville, MD, Accessed February 6, 2012, at http://www.ahrq.gov/fund/recoveryawards/

10.

Brewer NT, Salz T, Lillie SE: Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med. 2007, 146 (7): 502-510.CrossRefPubMed

11.

Agency for Healthcare Research and Quality: The Effective Health Care Program Stakeholder Guide 2011. July 2011, Rockville, MD, Accessed February 6, 2012, at http://www.ahrq.gov/clinic/epcpartner/stakeholderguide/stakeholdr.pdf

12.

Patient-Centered Outcomes Research Institute (PCORI). Washington, DC, Accessed February 1, 2012, at http://www.pcori.org/

13.

National Kidney Foundation: KDOQI Guidelines and Commentaries. 2009, Accessed January 20, 2012, at http://www.kidney.org/professionals/kdoqi/guidelines_commentaries.cfm

14.

London G, Coyne D, Hruska K, Malluche HH, Martin KJ: The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification. Clin Nephrol. 2010, 74 (6): 423-432.PubMedPubMedCentral

15.

Agency for Healthcare Research and Quality Effective Health Care Program: Screening for and Management of Chronic Kidney Disease Stages 1–3. July 2010, Accessed December 20, 2012, at http://www.effectivehealthcare.ahrq.gov/ehc/products/163/480/CKD%20Protocol%20with%20logos%207%2020%2010.pdf

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/13/74/prepub

Title: Setting an agenda for comparative effectiveness systematic reviews in CKD care
Authors: Deidra C Crews
Raquel C Greer
Jeffrey J Fadrowski
Michael J Choi
David Doggett
Jodi B Segal
Kemi A Fawole
Pammie R Crawford
L Ebony Boulware
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI: https://doi.org/10.1186/1471-2369-13-74

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2012

The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial

Unexpected outcome after sclerotherapy of simple renal cyst

Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial

A complex microdeletion 17q12 phenotype in a patient with recurrent de novo membranous nephropathy

Association between microalbuminuria and subclinical atherosclerosis evaluated by carotid artery intima-media in elderly patients with normal renal function

Patients with chronic kidney disease are at an elevated risk of dementia: A population-based cohort study in Taiwan

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials